|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mangiola A, Saulnier N, De Bonis P,
Orteschi D, Sica G, Lama G, Pettorini BL, Sabatino G, Zollino M,
Lauriola L, et al: Gene expression profile of glioblastoma
peritumoral tissue: An ex vivo study. PLoS One. 8:e571452013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jayamanne D, Wheeler H, Cook R, Teo C,
Brazier D, Schembri G, Kastelan M, Guo L and Back MF: Survival
improvements with adjuvant therapy in patients with glioblastoma.
ANZ J Surg. 88:196–201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lassman AB, van den Bent MJ, Gan HK,
Reardon DA, Kumthekar P, Butowski N, Lwin Z, Mikkelsen T, Nabors
LB, Papadopoulos KP, et al: Safety and efficacy of depatuxizumab
mafodotin + temozolomide in patients with EGFR-amplified, recurrent
glioblastoma: Results from an international phase I multicenter
trial. Neuro Oncol. 21:106–114. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Franceschi E, Minichillo S and Brandes AA:
Pharmacotherapy of glioblastoma: Established treatments and
emerging concepts. CNS Drugs. 31:675–684. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mangiola A, de Bonis P, Maira G, Balducci
M, Sica G, Lama G, Lauriola L and Anile C: Invasive tumor cells and
prognosis in a selected population of patients with glioblastoma
multiforme. Cancer. 113:841–846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Long H, Liang C, Zhang X, Fang L, Wang G,
Qi S, Huo H and Song Y: Prediction and analysis of key genes in
glioblastoma based on bioinformatics. Biomed Res Int.
2017:76531012017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ruiz-Ontañon P, Orgaz JL, Aldaz B,
Elosegui-Artola A, Martino J, Berciano MT, Montero JA, Grande L,
Nogueira L, Diaz-Moralli S, et al: Cellular plasticity confers
migratory and invasive advantages to a population of
glioblastoma-initiating cells that infiltrate peritumoral tissue.
Stem Cells. 31:1075–1085. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Van Meter T, Dumur C, Hafez N, Garrett C,
Fillmore H and Broaddus WC: Microarray analysis of MRI-defined
tissue samples in glioblastoma reveals differences in regional
expression of therapeutic targets. Diagn Mol Pathol. 15:195–205.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lama G, Mangiola A, Anile C, Sabatino G,
De Bonis P, Lauriola L, Giannitelli C, La Torre G, Jhanwar-Uniyal
M, Sica G and Maira G: Activated ERK1/2 expression in glioblastoma
multiforme and in peritumor tissue. Int J Oncol. 30:1333–1342.
2007.PubMed/NCBI
|
|
11
|
Kruthika BS, Jain R, Arivazhagan A,
Bharath RD, Yasha TC, Kondaiah P and Santosh V: Transcriptome
profiling reveals PDZ binding kinase as a novel biomarker in
peritumoral brain zone of glioblastoma. J Neurooncol. 141:315–325.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rickman DS, Tyagi R, Zhu XX, Bobek MP,
Song S, Blaivas M, Misek DE, Israel MA, Kurnit DM, Ross DA, et al:
The gene for the axonal cell adhesion molecule TAX-1 is amplified
and aberrantly expressed in malignant gliomas. Cancer Res.
61:2162–2168. 2001.PubMed/NCBI
|
|
18
|
Eckerich C, Zapf S, Ulbricht U, Müller S,
Fillbrandt R, Westphal M and Lamszus K: Contactin is expressed in
human astrocytic gliomas and mediates repulsive effects. Glia.
53:1–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Solly SK, Daubas P, Monge M, Dautigny A
and Zalc B: Functional analysis of the mouse myelin/oligodendrocyte
glycoprotein gene promoter in the oligodendroglial CG4 cell line. J
Neurochem. 68:1705–1711. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakagawa H, Yamada M, Kanayama T,
Tsuruzono K, Miyawaki Y, Tokiyoshi K, Hagiwara Y and Hayakawa T:
Myelin basic protein in the cerebrospinal fluid of patients with
brain tumors. Neurosurgery. 34:825–833. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Serão NV, Delfino KR, Southey BR, Beever
JE and Rodriguez-Zas SL: Cell cycle and aging, morphogenesis, and
response to stimuli genes are individualized biomarkers of
glioblastoma progression and survival. BMC Med Genomics. 4:492011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kong J, Cooper LA, Wang F, Gao J, Teodoro
G, Scarpace L, Mikkelsen T, Schniederjan MJ, Moreno CS, Saltz JH
and Brat DJ: Machine-based morphologic analysis of glioblastoma
using whole-slide pathology images uncovers clinically relevant
molecular correlates. PLoS One. 8:e810492013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ljubimova JY, Wilson SE, Petrovic LM,
Ehrenman K, Ljubimov AV, Demetriou AA, Geller SA and Black KL:
Novel human malignancy-associated gene (MAG) expressed in various
tumors and in some tumor preexisting conditions. Cancer Res.
58:4475–4479. 1998.PubMed/NCBI
|
|
24
|
Reis ST, Leite KR, Piovesan LF,
Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP,
Srougi M and Dall'Oglio MF: Increased expression of MMP-9 and IL-8
are correlated with poor prognosis of Bladder Cancer. BMC Urol.
12:182012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pathak JL, Bakker AD, Verschueren P, Lems
WF, Luyten FP, Klein-Nulend J and Bravenboer N: CXCL8 and CCL20
enhance osteoclastogenesis via modulation of cytokine production by
human primary osteoblasts. PLoS One. 10:e01310412015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kast RE: Glioblastoma invasion, cathepsin
B, and the potential for both to be inhibited by auranofin, an old
anti-rheumatoid arthritis drug. Cent Eur Neurosurg. 71:139–142.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lanzardo S, Conti L, Brioschi C,
Bartolomeo MP, Arosio D, Belvisi L, Manzoni L, Maiocchi A, Maisano
F and Forni G: A new optical imaging probe targeting αVβ3 integrin
in glioblastoma xenografts. Contrast Media Mol Imaging. 6:449–458.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen
P, Rafii S and Hicklin DJ: The vascular endothelial growth factor
receptor (VEGFR-1) supports growth and survival of human breast
carcinoma. Int J Cancer. 119:1519–1529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kane NM, Xiao Q, Baker AH, Luo Z, Xu Q and
Emanueli C: Pluripotent stem cell differentiation into vascular
cells: A novel technology with promises for vascular
re(generation). Pharmacol Ther. 129:29–49. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Calvo CF, Fontaine RH, Soueid J, Tammela
T, Makinen T, Alfaro-Cervello C, Bonnaud F, Miguez A, Benhaim L, Xu
Y, et al: Vascular endothelial growth factor receptor 3 directly
regulates murine neurogenesis. Genes Dev. 25:831–844. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Desbaillets I, Diserens AC, Tribolet N,
Hamou MF and Van Meir EG: Upregulation of interleukin 8 by
oxygen-deprived cells in glioblastoma suggests a role in leukocyte
activation, chemotaxis, and angiogenesis. J Exp Med. 186:1201–1212.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong ML, Prawira A, Kaye AH and Hovens CM:
Tumour angiogenesis: Its mechanism and therapeutic implications in
malignant gliomas. J Clin Neurosci. 16:1119–1130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gong J, Zhu S, Zhang Y and Wang J:
Interplay of VEGFa and MMP2 regulates invasion of glioblastoma.
Tumour Biol. 35:11879–11885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Egorova AA, Maretina MA and Kiselev AV:
VEGFA gene silencing in CXCR4-expressing cells via siRNA delivery
by means of targeted peptide carrier. Methods Mol Biol. 1974:57–68.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Keunen O, Johansson M, Oudin A, Sanzey M,
Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, et al:
Anti-VEGF treatment reduces blood supply and increases tumor cell
invasion in glioblastoma. Proc Natl Acad Sci USA. 108:3749–3754.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Latzer P, Shchyglo O, Hartl T, Matschke V,
Schlegel U, Manahan-Vaughan D and Theiss C: Blocking VEGF by
bevacizumab compromises electrophysiological and morphological
properties of hippocampal neurons. Front Cell Neurosci. 13:1132019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koch A, Polverini P, Kunkel S, Harlow LA,
DiPietro LA, Elner VM, Elner SG and Strieter RM: Interleukin-8 as a
macrophage-derived mediator of angiogenesis. Science.
258:1798–1801. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Strieter RM, Kunkel SL, Elner VM, Martonyi
CL, Koch AE, Polverini PJ and Elner SG: Interleukin-8. A corneal
factor that induces neovascularization. Am J Pathol. 141:1279–1284.
1992.PubMed/NCBI
|
|
40
|
Keane MP and Strieter RM: The role of CXC
chemokines in the regulation of angiogenesis. Chem Immunol.
72:86–101. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tada M, Suzuki K, Yamakawa Y, Sawamura Y,
Sakuma S, Abe H, van Meir E and de Tribolet N: Human glioblastoma
cells produce 77 amino acid interleukin-8 (IL-8(77)). J Neurooncol.
16:25–34. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Brat DJ, Bellail AC and Van Meir EG: The
role of interleukin-8 and its receptors in gliomagenesis and
tumoral angiogenesis. Neuro Oncol. 7:122–133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ahn SH, Park H, Ahn YH, Kim S, Cho MS,
Kang JL and Choi YH: Necrotic cells influence migration and
invasion of glioblastoma via NF-κB/AP-1-mediated IL-8 regulation.
Sci Rep. 6:245522016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sharma I, Singh A, Siraj F and Saxena S:
IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion
and vascular mimicry in glioblastoma. J Biomed Sci. 25:622018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Infanger DW, Cho Y, Lopez BS, Mohanan S,
Liu SC, Gursel D, Boockvar JA and Fischbach C: Glioblastoma stem
cells are regulated by interleukin-8 signaling in a tumoral
perivascular niche. Cancer Res. 73:7079–7089. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dwyer J, Hebda JK, Le Guelte A, Galan-Moya
EM, Smith SS, Azzi S, Bidere N and Gavard J: Glioblastoma
cell-secreted interleukin-8 induces brain endothelial cell
permeability via CXCR2. PLoS One. 7:e455622012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu YS, Hsu JW, Lin HY, Lai SW, Huang BR,
Tsai CF and Lu DY: Bradykinin B1 receptor contributes to
interleukin-8 production and glioblastoma migration through
interaction of STAT3 and SP-1. Neuropharmacology. 144:143–154.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hasan T, Caragher SP, Shireman JM, Park
CH, Atashi F, Baisiwala S, Lee G, Guo D, Wang JY, Dey M, et al:
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity
and enhances tumorigenicity in glioblastoma. Cell Death Dis.
10:2922019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Angara K, Borin TF, Rashid MH, Lebedyeva
I, Ara R, Lin PC, Iskander A, Bollag RJ, Achyut BR and Arbab AS:
CXCR2-expressing tumor cells drive vascular mimicry in
antiangiogenic therapy-resistant glioblastoma. Neoplasia.
20:1070–1082. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun S, Wang Q, Giang A, Cheng C, Soo C,
Wang CY, Liau LM and Chiu R: Knockdown of CypA inhibits
interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor
growth of glioblastoma cells through down-regulated NF-κB. J
Neurooncol. 101:1–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Davis ME: Glioblastoma: Overview of
disease and treatment. Clin J Oncol Nurs. 20 (Suppl 5):S2–S8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
